Bayer

Description

Bayer develops cell and gene therapies through its pharmaceutical business, combining cell-replacement and gene-delivery approaches to target neurological, cardiovascular, and eye diseases, including Parkinson’s disease and heart failure.

Related

• NTrans TechnologiesNTrans Technologies develops a non-viral delivery platform for cell and gene therapies, providing modular delivery solutions for…
• 21st.BIO21st.BIO A/S provides precision fermentation technology for proteins and peptides, using microbial strains, fermentation processes, and…
• 3H Biomedical3H Biomedical supplies primary human and animal cell-based products, RNA, DNA, assays and culture media for life science research, drug…
• AbbelightAbbelight provides an integrated bioimaging workflow combining advanced microscopy and nanoscopy platforms, ready-to-use reagents, and NEO…
• Ability PharmaceuticalsAbility Pharmaceuticals develops oral targeted anticancer compounds that induce selective autophagy-mediated cytotoxicity in cancer cells;…
• AACD PharmaACD Pharma develops bacteriophage-based biocontrol products and technologies for preventing and treating bacterial infections, with…
• AciesBioAciesBio provides microbial biotech services for strain engineering, scale-up process design, fermentation-broth processing, contract…
• ActitheraActithera develops precisely targeted radioligand therapies by linking radioactive isotopes to designed molecules, producing…
• ActiTrexxActiTrexx develops therapies based on activated regulatory T cells for autoimmune and autoinflammatory diseases, including ATreg/Actileucel…